Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes

Not Applicable

Completed

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT05802927
• Lead Sponsor: Abbott Nutrition

Brief Summary

A randomized, controlled, crossover design with three treatments to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-03-26
• Study First Submitted QC: 2023-03-26
• Study First Posted: 2023-04-07
• Study Start: 2023-07-05
• Status Verified: 2023-10
• Primary Completion: 2023-10-26
• Study Completion: 2023-10-26
• Last Update Submitted: 2023-10-26
• Last Update Posted: 2023-10-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Postprandial blood glucose	3 hours	Positive area under the curve (AUC) for blood glucose concentration from 0 to 180 minutes.

Secondary Outcome Measures

Name	Time	Method
Postprandial insulin	3 hours	Positive area under the curve (AUC) for blood insulin concentration from 0 to 180 minutes.
Appetite	3 hours	Negative/Positive area under the curve (AUC) for each item of Appetite questionnaire from 0 to 180 minutes.

Trial Locations

Locations (2)

Chulalongkorn University; 🇹🇭 Bangkok, Thailand

Siriraj Hospital; 🇹🇭 Bangkok, Thailand